Annual CFF
$2.84 M
-$657.00 K-18.80%
December 31, 2023
Summary
- As of February 7, 2025, VCYT annual cash flow from financing activities is $2.84 million, with the most recent change of -$657.00 thousand (-18.80%) on December 31, 2023.
- During the last 3 years, VCYT annual CFF has fallen by -$200.76 million (-98.61%).
- VCYT annual CFF is now -99.52% below its all-time high of $596.32 million, reached on December 31, 2021.
Performance
VCYT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$10.29 M
+$10.30 M+93636.36%
September 30, 2024
Summary
- As of February 7, 2025, VCYT quarterly cash flow from financing activities is $10.29 million, with the most recent change of +$10.30 million (+93636.36%) on September 30, 2024.
- Over the past year, VCYT quarterly CFF has increased by +$9.64 million (+1495.19%).
- VCYT quarterly CFF is now -98.26% below its all-time high of $591.01 million, reached on March 31, 2021.
Performance
VCYT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$10.06 M
+$10.18 M+8482.50%
September 30, 2024
Summary
- As of February 7, 2025, VCYT TTM cash flow from financing activities is $10.06 million, with the most recent change of +$10.18 million (+8482.50%) on September 30, 2024.
- Over the past year, VCYT TTM CFF has increased by +$7.22 million (+254.56%).
- VCYT TTM CFF is now -98.73% below its all-time high of $794.83 million, reached on March 31, 2021.
Performance
VCYT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
VCYT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.8% | +1495.2% | +254.6% |
| 3 y3 years | -98.6% | +220.0% | -98.3% |
| 5 y5 years | -95.2% | +114.5% | -92.1% |
VCYT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.5% | at low | at high | +1290.9% | -98.3% | +8482.5% |
| 5 y | 5-year | -99.5% | at low | -98.3% | +1290.9% | -98.7% | +8482.5% |
| alltime | all time | -99.5% | +1401.4% | -98.3% | +222.6% | -98.7% | +4714.2% |
Veracyte Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $10.29 M(<-9900.0%) | $10.06 M(-8482.5%) |
| Jun 2024 | - | -$11.00 K(-98.7%) | -$120.00 K(-141.7%) |
| Mar 2024 | - | -$864.00 K(-234.0%) | $288.00 K(-89.8%) |
| Dec 2023 | $2.84 M(-18.8%) | $645.00 K(+486.4%) | $2.84 M(+24.2%) |
| Sep 2023 | - | $110.00 K(-72.3%) | $2.29 M(-37.6%) |
| Jun 2023 | - | $397.00 K(-76.4%) | $3.66 M(+14.8%) |
| Mar 2023 | - | $1.69 M(+1711.8%) | $3.19 M(-8.7%) |
| Dec 2022 | $3.49 M(-99.4%) | $93.00 K(-93.7%) | $3.49 M(-2.2%) |
| Sep 2022 | - | $1.49 M(-2081.3%) | $3.57 M(-32.6%) |
| Jun 2022 | - | -$75.00 K(-103.8%) | $5.30 M(-27.3%) |
| Mar 2022 | - | $1.99 M(+1050.3%) | $7.30 M(-98.8%) |
| Dec 2021 | $596.32 M(+192.9%) | $173.00 K(-94.6%) | $596.32 M(-0.5%) |
| Sep 2021 | - | $3.21 M(+67.4%) | $599.06 M(-24.5%) |
| Jun 2021 | - | $1.92 M(-99.7%) | $793.36 M(-0.2%) |
| Mar 2021 | - | $591.01 M(>+9900.0%) | $794.83 M(+290.4%) |
| Dec 2020 | $203.59 M(+59.9%) | $2.91 M(-98.5%) | $203.59 M(-0.0%) |
| Sep 2020 | - | $197.51 M(+5726.3%) | $203.65 M(+1762.7%) |
| Jun 2020 | - | $3.39 M(-1647.9%) | $10.93 M(-91.9%) |
| Mar 2020 | - | -$219.00 K(-107.4%) | $135.46 M(+6.4%) |
| Dec 2019 | $127.29 M(+113.9%) | $2.96 M(-38.2%) | $127.29 M(+0.9%) |
| Sep 2019 | - | $4.80 M(-96.2%) | $126.15 M(-29.1%) |
| Jun 2019 | - | $127.92 M(-1623.9%) | $177.88 M(+254.3%) |
| Mar 2019 | - | -$8.39 M(-558.9%) | $50.20 M(-15.6%) |
| Dec 2018 | $59.50 M | $1.83 M(-96.8%) | $59.50 M(+5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $56.53 M(>+9900.0%) | $56.48 M(>+9900.0%) |
| Jun 2018 | - | $239.00 K(-73.5%) | $394.00 K(+191.9%) |
| Mar 2018 | - | $901.00 K(-175.8%) | $135.00 K(-161.9%) |
| Dec 2017 | -$218.00 K(-100.4%) | -$1.19 M(-368.8%) | -$218.00 K(-100.7%) |
| Sep 2017 | - | $442.00 K(-2310.0%) | $33.17 M(+0.4%) |
| Jun 2017 | - | -$20.00 K(-103.6%) | $33.05 M(+0.3%) |
| Mar 2017 | - | $548.00 K(-98.3%) | $32.93 M(-37.1%) |
| Dec 2016 | $52.33 M(+38.7%) | $32.20 M(>+9900.0%) | $52.33 M(+160.1%) |
| Sep 2016 | - | $317.00 K(-334.8%) | $20.11 M(+1.6%) |
| Jun 2016 | - | -$135.00 K(-100.7%) | $19.79 M(-65.6%) |
| Mar 2016 | - | $19.95 M(<-9900.0%) | $57.59 M(+52.6%) |
| Dec 2015 | $37.73 M(+8554.4%) | -$12.00 K(+200.0%) | $37.73 M(+0.0%) |
| Sep 2015 | - | -$4000.00(-100.0%) | $37.73 M(-0.3%) |
| Jun 2015 | - | $37.66 M(>+9900.0%) | $37.84 M(+5906.2%) |
| Mar 2015 | - | $92.00 K(-584.2%) | $630.00 K(+44.5%) |
| Dec 2014 | $436.00 K(-99.4%) | -$19.00 K(-117.4%) | $436.00 K(-99.3%) |
| Sep 2014 | - | $109.00 K(-75.7%) | $59.82 M(+0.0%) |
| Jun 2014 | - | $448.00 K(-539.2%) | $59.81 M(-22.7%) |
| Mar 2014 | - | -$102.00 K(-100.2%) | $77.36 M(-0.4%) |
| Dec 2013 | $77.66 M(+415.5%) | $59.36 M(>+9900.0%) | $77.66 M(+324.5%) |
| Sep 2013 | - | $101.00 K(-99.4%) | $18.30 M(+0.6%) |
| Jun 2013 | - | $18.00 M(+9130.8%) | $18.20 M(+9230.8%) |
| Mar 2013 | - | $195.00 K | $195.00 K |
| Dec 2012 | $15.06 M(-19.2%) | - | - |
| Dec 2011 | $18.65 M | - | - |
FAQ
- What is Veracyte annual cash flow from financing activities?
- What is the all time high annual CFF for Veracyte?
- What is Veracyte annual CFF year-on-year change?
- What is Veracyte quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Veracyte?
- What is Veracyte quarterly CFF year-on-year change?
- What is Veracyte TTM cash flow from financing activities?
- What is the all time high TTM CFF for Veracyte?
- What is Veracyte TTM CFF year-on-year change?
What is Veracyte annual cash flow from financing activities?
The current annual CFF of VCYT is $2.84 M
What is the all time high annual CFF for Veracyte?
Veracyte all-time high annual cash flow from financing activities is $596.32 M
What is Veracyte annual CFF year-on-year change?
Over the past year, VCYT annual cash flow from financing activities has changed by -$657.00 K (-18.80%)
What is Veracyte quarterly cash flow from financing activities?
The current quarterly CFF of VCYT is $10.29 M
What is the all time high quarterly CFF for Veracyte?
Veracyte all-time high quarterly cash flow from financing activities is $591.01 M
What is Veracyte quarterly CFF year-on-year change?
Over the past year, VCYT quarterly cash flow from financing activities has changed by +$9.64 M (+1495.19%)
What is Veracyte TTM cash flow from financing activities?
The current TTM CFF of VCYT is $10.06 M
What is the all time high TTM CFF for Veracyte?
Veracyte all-time high TTM cash flow from financing activities is $794.83 M
What is Veracyte TTM CFF year-on-year change?
Over the past year, VCYT TTM cash flow from financing activities has changed by +$7.22 M (+254.56%)